Conference Coverage

Overtreatment common in high-risk diabetes patients

Publish date: July 22, 2013

 

AT THE ADA ANNUAL SCIENTIFIC SESSIONS

The Department of Veterans Affairs supported the study. Dr. Pogach reported having no financial conflicts of interest.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Roche halts studies of experimental type 2 diabetes drug
MDedge Internal Medicine
Insulin boosted memory in patients with high-risk Alzheimer's allele
MDedge Internal Medicine
Would patients open wallets for fewer diabetes drug doses?
MDedge Internal Medicine
Two meals per day better than six in T2DM
MDedge Internal Medicine
Pilot study: Vitamin D promising for diabetic pain
MDedge Internal Medicine
Octogenarians hard hit by insulin adverse events
MDedge Internal Medicine
Aging-related functional decline boosts diabetes risk
MDedge Internal Medicine
Add-on dapagliflozin achieves combined weight/HbA1c reduction more often than glipizide
MDedge Internal Medicine
Novel insulin/GLP-1 combo succeeds in phase III trial
MDedge Internal Medicine
Osteoprotegerin ups risk of vascular events in type 1 diabetes
MDedge Internal Medicine